Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents

By  

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 186-191

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Activation of p53 in Cancer Cells

By  

Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. : 631-639

Bentham Science Publishers

Access to resources Recommend Favorite

ATM/ATR-related checkpoint signals mediate arsenite-induced G₂/M arrest in primary aortic endothelial cells

By Tsou Tsui-Chun   Tsai Feng-Yuan   Yeh Szu-Ching   Chang Louis  

Archives of Toxicology, Vol. 80, Iss. 12, 2006-12 ,pp. : 804-810

Springer Publishing Company

Access to resources Recommend Favorite

p53 Regulation of Energy Metabolism and Mitochondria Regulation of p53 in Cancer Cells: An Insight into the Role of Manganese Superoxide Dismutase

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 3, 2013-01 ,pp. : 261-273

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of the p53 pathway in cancer stem cells

By Prabhu Varun V   Allen Joshua E   Hong Bo   Zhang Shengliang   Cheng Hairong   El-Deiry Wafik S  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite